Physician profile
Javier E Andrade
NPI 1376747964
$20,431.83
in general payments reported to CMS, 2019-2025
15 companies · $6,587 in 2025
The $6,587 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $270 · 2021: $17.31 · 2022: $307 · 2023: $11K · 2024: $1,857 · 2025: $6,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Food and Beverage: $3,125 · Travel and Lodging: $2,704 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,250.00 |
| Food and Beverage | $3,124.72 |
| Travel and Lodging | $2,704.18 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,934.11 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $1,937.39 | 2023-2025 | Ligasure, Signia |
| Novo Nordisk INC | $845.33 | 2019-2025 | Wegovy, Ozempic |
| Baxter Healthcare | $583.98 | 2024-2025 | Tisseel, Floseal, Peri-Strips Dry |
| Davol INC. | $257.86 | 2022 | |
| Becton, Dickinson and Company | $229.47 | 2023 | Phasix Mesh |
| Covidien LP | $220.95 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $131.64 | 2019 | |
| Glaxosmithkline, LLC. | $125.00 | 2025 | Arexvy |
| Ethicon US, LLC | $49.17 | 2022 | |
| Smith+Nephew, INC. | $46.90 | 2020-2024 | Collagenase Santyl |
| Boston Scientific Corporation | $23.67 | 2019 | |
| Abbvie INC. | $17.31 | 2021 | |
| Allergan, INC. | $14.59 | 2020 | |
| Solventum Corporation | $14.46 | 2025 | V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Andrade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.